About Us (Why Choose Us)
We are committed to offering patients the latest advances in treatment. Our pioneering research efforts include the invention of three-dimensional treatment planning, now a standard practice worldwide. We have continued this research by developing a unique method of delivering intensity modulated radiation therapy (IMRT). In addition to these technical developments, our scientists are designing better ways of combining medications with radiation so as to more effectively treat tumors, spare normal tissue from damage and minimize side effects.
Cutting Edge Treatment
Radiation Oncology at Michigan receives more research funding from the National Institutes of Health than any radiation oncology department in the nation.
- The University of Michigan Hospitals and Health Centers is listed among the best hospitals in the nation and once again is the only hospital in Michigan to make the honor roll of “America’s Best Hospitals” in the annual U.S.News & World Report rankings.
- Innovation of our work has been recognized by the fact that we are one of the top National Cancer Institute-funded departments in the country, and receive more funding than all other radiation oncology programs in the state combined.
- By working collaboratively with the U-M's renowned Comprehensive Cancer Center as well as our statewide Radiation Oncology Network, we provide accessible, appropriate patient care throughout Michigan and across multiple disciplines. All patients are seen within 72 hours of the time they call for a consultation if they choose.
- We bring fundamental discoveries in cancer biology and medical physics directly to the clinic to help patients.
- The department has developed breakthrough radiotherapy and expertise in combining radiation with chemotherapy to deliver a new generation of molecularly targeted treatments such as:
- External beam radiation, including intensity-modulated radiation therapy (IMRT)
- Prostate seed implants
- Stereotactic radiosurgery and radiotherapy for lesions anywhere in the body
- High dose-rate (HDR) and low dose-rate (LDR) brachytherapy
- We produce competent clinical and scientific leaders with a training program that integrates biology laboratory, medical physics, clinic experience and symptom management.
- Faculty are actively involved in developing the latest clinical trials, departmentally and through cooperative group studies (Radiation Therapy Oncology Group, Southwest Oncology Group, Children’s Cancer Study Group and others).
- State-of-the-art telemedicine and videoconferencing make it possible to evaluate a patient at one partner site and perform radiation treatment planning at a different site. Every case within the Radiation Oncology Network is reviewed by U-M faculty physicians assuring the highest level of care.